Tandem Diabetes Care (TNDM) Current Assets (2013 - 2026)

Tandem Diabetes Care has reported Current Assets for 14 years, with the latest figure at $887.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 33.71% year-over-year to $887.1 million; the trailing twelve-month figure through Mar 2026 stood at $887.1 million (up 33.71% YoY), and the FY2025 full-year result was $618.1 million, down 14.68% from the prior year.
• Current Assets for Q1 2026 stood at $887.1 million, up from $618.1 million in the prior quarter.
• The five-year high for Current Assets was $887.1 million in Q1 2026, with the low at $614.8 million in Q2 2025.
• Historically, Current Assets has averaged $747.8 million across 5 years, with a median of $752.8 million in 2024.
• Annual changes were most pronounced in 2025 — Current Assets fell 18.05% — and 2026, when it soared 33.71%.
• Tandem Diabetes Care's Current Assets stood at $850.0 million in 2022, then declined by 12.0% to $748.0 million in 2023, then retreated by 3.14% to $724.5 million in 2024, then retreated by 14.68% to $618.1 million in 2025, then surged by 43.51% to $887.1 million in 2026.
• The last three Current Assets figures came in at $887.1 million (Q1 2026), $618.1 million (Q4 2025), and $616.9 million (Q3 2025), per Business Quant data.